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INTRODUCTION:  Ciliated  hepatic  foregut  cysts  (CHFC)  are  rare,  typically  benign  liver  lesions.  Primary
squamous  cell  carcinoma  (SCC)  of the  liver  is  also  a rare entity  with  only  approximately  25 reported
cases  in  the  literature.  Recently,  there  have  been  four reports  of  malignant  transformation  of  CHFC  into
primary  squamous  cell  carcinoma  of  the  liver.  Here  we  report  a ﬁfth  with  unique  presentation  and  review
the  literature.
PRESENTATION  OF  CASE:  A 34  year-old  man,  with  a  history  of ulcerative  colitis,  was  incidentally  found
to  have  a  10  cm lesion  in  the  right  anterior  sector  plus  left medial  section  of  the  liver on  computerized
tomography  (CT)  scan.  The  patient  was  asymptomatic  at presentation  and  neoplastic  markers  were  not
elevated.  Sequential  transarterial  chemoembolization  (TACE)  and  portal  vein  embolization  (PVE)  allowed
for  left  lateral  section  plus  segment  1 hypertrophy  and subsequent  resection.  Histology  later  revealed
the  cyst  to be a CHFC  and  showed  its malignant  transformation.  At  6 month  follow-up,  the  patient  has
lung  and  abdominal  recurrence.
DISCUSSION: With  now  the  ﬁfth  case  of  malignant  transformation  of CHFC  being  reported,  approximately
5%  of all  reported  CHFC  have  undergone  malignant  transformation.  This  frequency,  taken  together  with
the  aggressive  disease  course  and  poor prognosis,  suggests  that  CHFC  must  not  be presumed  benign  and
should  be  regarded  with  clinical  suspicion.
CONCLUSION: Accurate  diagnosis  of CHFC  is  mandatory  given  its  potential  malignant  transformation.  Even
in  asymptomatic  CHFC,  surgical  excision  is  recommended.  In addition,  in  cases  of  otherwise  unresectable
lesions,  sequential  TACE  and  PVE  may  provide  optimal  hypertrophy  of future  liver remnant.
© 2013 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. 
 . Introduction
Ciliated hepatic foregut cysts (CHFC) are rare, typically benign
iver lesions of congenital origin. During embryologic development,
he primitive foregut gives rise to the tracheobronchial tree, and it
s speculated that the common origin of the esophagus and liver
ccounts for the histological ﬁndings in ciliated hepatic foregut
ysts.1 Despite ﬁrst being described in 1857 by Friedreich, a litera-
ure review reveals only about 100 reported cases of CHFC.2 While
his number may  not reﬂect the prevalence of these cysts due to
heir benign, asymptomatic nature, it is agreed that CHFC are an
ncommon ﬁnding.3
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ttp://dx.doi.org/10.1016/j.ijscr.2013.07.030While the previous belief was  that CHFC were benign lesions
with rare morbidity, there have been four recent reports of malig-
nant transformation of CHFC into primary squamous cell carcinoma
(SCC) of the liver.1,3,5,6 Primary SCC of the liver is itself a very
rare entity with approximately 25 reported cases in the literature.7
Pathogenesis of primary SCC of the liver is not entirely clear but
previous cases have been associated with various diseases includ-
ing non-parasitic cysts, hepatic cirrhosis, hepatolithiasis, hepatic
teratoma, and Caroli’s disease.7,8 There has been only one reported
case of primary SCC without latent hepatic insult.7
Hepatic primary SCC is highly malignant with high rates of
recurrence and poor overall prognosis.8 The disease state is typi-
cally advanced upon diagnosis and presents clinically as right upper
quadrant pain, vague fullness, jaundice, weight loss, nausea, and/or
Open access under CC BY-NC-ND license.vomiting. Hepatomegaly and tenderness with palpitation may  be
present.7 The outcomes of cases in the literature suggest a progno-
sis of less than 1 year survival with only isolated cases achieving 5
year survival.7,8 There is no current treatment standard, but most
commonly, TACE, surgical resection, and radiation therapy have
been utilized.7,8
s Ltd. Open access under CC BY-NC-ND license. 
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aig. 1. Incidental ﬁnding of hypoenhancing hepatic lesion noted on CT conducted
n  response to elevated ESR and CRP.
Herein, this report identiﬁes a ﬁfth case of primary SCC of the
iver arising from a CHFC. This case is unique in that the liver
esion was asymptomatic and was found incidentally on com-
uted tomography (CT). In addition, successful management with
equential transcatheter arterial chemoembolization (TACE) and
ortal vein embolization (PVE) allowed for a therapeutic surgical
ntervention.
. Case presentation
A 34-year-old man  with a past medical history remarkable for
lcerative colitis underwent a CT scan due to an elevated C-reactive
rotein (CRP) and erythrocyte sedimentation rate (ESR), in addition
o anemia on his routine blood work. Unexpectedly, the CT revealed
 10 cm hypoenhancing lesion in the right anterior sector plus left
edial section of the liver (Fig. 1).
The patient was asymptomatic and no noticeable orangomegaly
r pain was found with palpation. Laboratory studies revealed
nemia suggestive of iron deﬁciency, normal serological tumor
arkers (CEA, CA 19-9, and AFP), viral hepatitis panel was  neg-
tive, and CRP/ESR were elevated at 3.0 mg/dL and 74 mm/hr
espectively. A dedicated liver magnetic resonance imaging (MRI)
as performed and revealed a heterogeneous hepatic lesion in
ig. 3. Left lateral segment hypertrophy. The image at left shows the liver before portal ve
t  right demonstrates scatter from embolization of the right portal vein, as well as signiﬁFig. 2. MRI  revealing mass in the right anterior sector plus left medial section of the
liver with internal cystic component.
segments 4, 5, and 8. The lesion was noted to have an internal
cystic component (Fig. 2). Computer generated volume assessment
of the liver was  performed at this time and it was found that
segments 1, 2, and 3 comprised only 18% of the total liver volume.
Subsequent biopsy of the lesion showed it to be SCC. The patient
underwent lipiodol-based transarterial chemoebolization (TACE)
of the right hepatic artery and segment 4 branches. This was fol-
lowed by right portal vein embolization (PVE) two weeks later.
Six weeks after PVE, cross sectional imaging demonstrated that
segments 1,2, and 3 had hypertrophied from 18% to 33% of total
liver volume, providing an adequate liver remnant for right tri-
sectionectomy (Fig. 3). The patient tolerated the procedure well
and had an uncomplicated recovery. At 6 months, surveillance
imaging demonstrated evidence of extrahepatic recurrence (lung
and abdominal). The patient is currently receiving a systemic
chemotherapy regimen of carboplatin and paclitaxel.
3. Histology
The liver specimen demonstrated a smooth mottled capsule
with a 13 cm × 7 cm rough white–gray nodular area exhibiting
overlying ﬁbrous adhesions. A well-circumscribed yellow–gray
mass measuring 14 cm × 12.5 cm × 10.5 cm and a cyst, central
within the mass measuring 5.5 cm × 5 cm × 4.5 cm, were revealed
in embolization (PVE), with a small left lateral segment (1067.391 cm3). The ﬁgure
cant hypertrophy of the left lateral segment (1801.602 cm3).
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Nig. 4. Transition of normal ciliated foregut cyst wall (A) to in situ squamous cell ca
tself  is thinner and contains fewer mitoses, which are appropriately located along
requent, and are no longer limited to locations along the basement membrane.
y sectioning. The cyst wall exhibited a smooth to focally gran-
lar surface and was ﬁlled with a soft tan–gray tumor material.
hree well-circumscribed nodules adjacent to the large mass were
resent.
Microscopically, the tumor showed areas of conﬂuent geo-
raphic necrosis. Immunohistochemical staining demonstrated
umor cells positive for CK 5/6 and p40, but negative for p16. There
ere no lymph node metastases in the 3 nodes examined. The cyst
as lined with pseudostratiﬁed ciliated columnar epithelium and
ad regions of wall-thickening (Fig. 4). The tumor showed sheets
f neoplastic cells with eosinophilic cytoplasm and round-to-oval
uclei. It was determined that the tumor was poorly differentiated
quamous cell carcinoma. The resection margins were negative for
alignancy.. Discussion
Malignant transformation of ciliated hepatic foregut cysts is
xceedingly rare.6 Since CHFC were ﬁrst described in 1857, only ﬁve
able 1
eview of ﬁve reported cases of malignant transformation of CHFC in the English Literatu
Case Age/gender Presentation Pathologica
1 51 M 1-month epigastric pain made
worse by eating Mild RUQ pain
with palpitation
Cyst occupy
space
12 cm × 10 c
size
2  21 M 6-month history of vague
fullness
Cyst occupy
VI
Mild RUQ pain, fever, and 13 kg
weight loss
Greatest dia
10 cm
3  40 F RUQ pain with back and
thoracic pain
Cyst occupy
13 cm × 9 cm
4  60 F 1-month history of vague
fullness
Tumor occu
RUQ pain on palpitation, w/o
peritoneal signs
7 cm × 6 cm
Mutiple sm
3–5 mm in s
5  34 M Asymptomatic Tumor occu
V, and VIII
Central cyst
5.5 cm × 5 c
ote: *** indicates this paper, RUQ = Right upper quadrant.a (B). On the left (A), the cyst wall resembles that of a bronchogenic cyst. The wall
asement membrane. On the right (B), the wall is thicker. Here, mitoses are more
such cases, including this one, have been reported (Table 1).1,4–6
Due to their normally asymptomatic nature, CHFC are usually
found incidentally during surgery (6%), via imaging studies (40%),
or post mortem at autopsy (26%). The remainder present with
abdominal symptoms.9 Diagnosis of CHFC preoperatively is difﬁ-
cult because radiographic studies cannot differentiate CHFC from
other cysts and thus, biopsy is typically required.4 Malignant trans-
formation of CHFC is even more difﬁcult to diagnose preoperatively
due to the sampling error associated with aspiration cytology, and
the difﬁculty associated with distinguishing benign and neoplastic
cysts with imaging studies.4 In addition, serological tumor mark-
ers such as CA 19-9 seem to lack efﬁcacy for diagnosis as they
have been demonstrated to be elevated in benign CHFC and may
be normal in malignancy, as in this case.6 Most CHFC are uniloc-
ular, and rarely exceed 4 cm in diameter.9 Interestingly, with the
exception of the case reported by Zhang et al. which presented
with multiple small cysts (3–5 mm), the remaining CHFC that have
undergone malignant transformation have been larger than 5 cm in
diameter.1
re.
l features Outcome References
ing the subhepatic Uneventful postoperative
course, but died 2 months later
[6]
m × 0.1–0.7 cm in
ing segments V and Uneventful postoperative
course,
[5]
meter measuring but died 9 months later after
widespread intra-abdominal
recurrence
ing segment V Outcome not provided [4]
 × 7 cm in size
pying segment VI Alive after 6-month follow-up [1]
 × 5 cm in size
all cystic lesions,
ize
pying segments IV, Lung and abdominal
recurrence at 6-months
***
 measuring
m × 4.5 cm
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It is difﬁcult to deﬁnitively say that primary SCC of the liver
s a result of malignant transformation of the CHFC wall. However,
fter establishing no extrahepatic disease, a primary hepatic cancer
hould be suspected. In addition, given that the cyst was  adjacent
o and focally connected with the squamous cell carcinoma in this
ase, it was felt that the cyst wall was the origin of pathogenesis.
quamous cell metaplasia, dysplasia, and malignant transforma-
ion of the ciliated columnar epithelium is the proposed mechanism
f pathogenesis.
CHFC have historically been considered non-neoplastic lesions.
owever, with the recent publication of now ﬁve cases of squamous
ell carcinoma arising from CHFC, approximately 5% of reported
HFC have demonstrated malignant transformation, suggesting the
eed for serious clinical consideration. Due to the aggressive nature
f these malignant lesions, it is mandatory that thorough patholog-
cal and radiological studies be conducted in order to differentiate
ysts upon discovery. Differential diagnoses of large hepatic cysts
nclude: parasitic cyst, simple hepatic cyst, and biliary cyst, as well
s non-cystic lesions if cysts are ﬁlled with dense ﬂuid or demon-
trate metastatic change.1,5,9 The ciliated epithelium of CHFC is
nique and can serve as a differentiating histological marker.
Our case and the existing literature suggest that primary SCC
f the liver is an aggressive disease with poor prognosis. Only iso-
ated cases have been reported in which 5 year survival has been
chieved and Zhao et al. reports that survival does not usually
xceed 1 year.7,8 In part due to the rarity of these lesions, there
s no standard recommended treatment. Kaji et al. reported a case
f primary hepatic SCC that responded very well to chemothera-
eutics (cis-diaminedichloro-platinum (CDDP) and 5-ﬂuorouracil)
dministered via hepatic arterial injection.10 In addition, recent
tudies have demonstrated the efﬁcacy of sequential TACE and PVE
n management of hepatocellular carcinoma.11 This approach has
emonstrated signiﬁcant increases in the future liver remnant (FLR)
nd longer recurrence-free and overall survival versus PVE alone.11
n this case, sequential TACE and PVE was well tolerated and was
uccessful in inducing sufﬁcient FLR hypertrophy for surgical inter-
ention.
. Conclusion
CHFC should not be presumed benign and must be regarded
ith suspicion. The possibility of malignant transformation of CHFC
nd aggressive nature of primary hepatic SCC necessitates accu-
ate diagnosis of hepatic cysts. Given this review of cases, we
ecommend surgical excision of CHFC. Also, in cases of otherwise
nresectable primary SCC of the liver, sequential TACE and PVE may
nduce optimal FLR hypertrophy to allow for surgical resection.onsent
Written informed consent was obtained from the patient for
ublication of this case report and case series and accompanying
1PEN  ACCESS
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